Severe scalp hair loss in a female patient with acromegaly treated with lanreotide autogel after unsuccessful surgery

Scalp hair loss is an underreported adverse event of somatostatin analogs therapy that in severe cases may require treatment withdrawal. It can be related to an acute decrease in GH/IGF-1 levels, but a direct effect cannot be ruled out.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clin Case Rep
Hauptverfasser: Alvarez-Escola, Cristina, Cárdenas-Salas, Jersy J, Pelegrina, Beatriz, Sanz-Valtierra, Angel, Lecumberri, Beatriz
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley & Sons, Ltd 2015
Schlagworte:
Case Reports
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4641480/
https://ncbi.nlm.nih.gov/pubmed/26576278
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.388
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge